GI Supply Introduces Spot® Ex Endoscopic Tattoo
January 15, 2017 | Camp Hill, PA

GI Supply, Inc. announced today the U.S. launch of the Spot® Ex Endoscopic Tattoo, which helps gastroenterologists and surgeons take the next step in the fight against colon cancer. Spot Ex is now indicated for clinical surveillance in addition to surgical localization. Leading societies recommend tattooing of malignant lesions, post-polypectomy sites, and difficult-to-detect polyps to enable future identification at follow-up colonoscopy or surgery.1
Read Full Story

Recently published national data highlighted that colon cancer incidence and mortality rates are rising in younger patients.2,3 Additionally, new clinical guidelines have been released from the European Society Gastrointestinal Endoscopy (ESGE) that recommend tattooing all lesions that need to be followed-up at future colonoscopy or surgery.1

Spot Ex helps clinicians combat these trends and implement the guidelines by offering expanded indications that include long-term clinical surveillance. The new Spot Ex Endoscopic Tattoo provides a permanent mark, enabling a lifetime of patient care follow-up. Spot Ex is also 50% darker than the current Spot product, making the tattoo easier-to-find4 and helping endoscopists and surgeons manage time and productivity pressures.

“As a therapeutic endoscopist at Northwestern Memorial Hospital, I am often referred complex polyp removal cases. In those scenarios, it is very beneficial to have the polyp tattooed for easy identification,” said Dr. Sri Komanduri, Gastroenterologist. “In addition, post-resection I typically follow-up with the patient within six months to ensure there is no adenoma recurrence, and a tattoo helps with that surveillance. The new Spot Ex tattoo will help me monitor that patient as long as needed.”

“In my practice at San Antonio Gastroenterology Associates we have seen a steady increase in young patients being diagnosed with colon cancer. Fortunately, earlier diagnosis and new endoscopic therapies we offer are working,” said Dr. Antonio Serna, Gastroenterologist. “But these patients need to come back for many years of surveillance. Spot Ex gives me a way to feel confident in my assessment of cancer remission or recurrence.”

“We’re excited to aid in the fight against colon cancer and advance the science of endoscopic tattooing with a permanent and cost-effective solution for gastroenterologists and surgeons. Our mission at GI Supply is to help more GI physicians do more advanced endoscopic procedures safely and efficiently, and Spot Ex is a great next step in meeting those needs,” said Luke Johnson, CEO of GI Supply.

1. Ferlitsch M, Moss A, Hassan C, et al. Colorectal polypectomy and endoscopic mucosal resection (EMR): ESGE Clinical Guideline. 2017.

Read the guidelines at

2. Siegel R. et al. JNCI J Natl Cancer Inst. 2017
3. Siegel R. et al. JAMA. 2017
4. Lee. P., Finding Endoscopic Tattoos: The Impact of Contrast. GI Supply. 2018.

About GI Supply: GI Supply, Inc., a private company based in Camp Hill, PA, was founded nearly 30 years ago by Dr. Frank Jackson, a gastroenterologist and entrepreneur, to help solve many of the clinical challenges he faced in daily practice. Today, GI Supply products are used around the world daily by gastroenterologists and colorectal surgeons in more than 40 countries. We’d love for you to join them. Visit for more information.

Orders can be placed by phone at (800) 451-5797 or by Email at



Contact: Dan McCoy, Vice President, Marketing

Phone: +1-312-608-1745



An Evidence-based Protocol for Endoscopic Tattoo
November 13, 2017 | Camp Hill, PA

Spot® Endoscopic Marker is clinically proven and society recommended as the standard of care for clinical surveillance and surgical localization.  Despite calls for standardization in clinical literature as recent as the May 2017 Journal of the Royal Society of Medicine article “Endoscopic Tattoo: the importance and need for standardized guidelines and protocol”, no such protocol exists in scientific literature.
Read Full Story

To help in the fight against colon cancer, GI Supply has developed an evidence-based protocol that will help Endoscopists decide whether to tattoo a lesion for further surveillance. This first of it’s kind evidence-based protocol is built based on the recently released European Society for Gastrointestinal Endoscopy (ESGE) practice guidelines for EMR and polypectomy, which provides the most comprehensive recommendations to date. The protocol is laid out as an easy to implement decision-tree Endoscopists can follow in daily practice.

Click below to download the protocol.

Download Now


GI Supply Partners with Global Medicine to Support Russian Gastroenterologists
October 20, 2017 | St Petersburg, Russia

As part of GI Supply’s continued global expansion, GI Supply has appointed Global Medicine LLC as their partner in the Russian Federation.
Read Full Story

With a population of over 143m and more than 60,000 cases of colorectal cancer every year, there is a clear need to support Russian gastroenterologists with products such as the Spot Endoscopic Marker.

Veronika Akhmadieva, MD of Global Medicine, said “Our company is pleased to present a product as innovative as Spot to the Russian market! We look forward to working with GI Supply to help surgeons fight colorectal cancer with Spot, by improving the accuracy of lesion marking in the digestive tract, and helping to provide better patient outcomes.”

We look forward to working with Veronika and her team as GI Supply enters this exciting market.

Global Medicine LLC,
Business Centre Zolotaya Shpalernaya,
54 Shpalernaya Street,
St. Petersburg,
Russia Federation

Phone: +7(812)401-42-43

GI Supply Partners with Boston Medical to Bring Spot® to Croatia
September 7, 2017 | Camp Hill, PA

Spot® Endoscopic Marker is now available in Croatia from Boston Medical!
Read Full Story

GI Supply and Boston Medical are helping Croatian gastroenterologists Win The Fight Against Colon Cancer by partnering to offer Spot Endoscopic Marker in this growing market. With more than 25 published clinical studies, and new guidelines from ESGE calling for tattooing all lesions gastroenterologists need to see at future colonoscopy or surgery, Spot will enable clinicians to monitor lesions post-polypectomy and help surgical partners localize lesions faster.

Lašćinska cesta 14
Zagreb, 10 000
Phone: +385 1 4002 100
Fax: +385 1 4002 105

2017 Edition of Meducate® Patient Education Brochures Now Available
July 10, 2017 | Camp Hill, PA

Meducate® Patient Education Brochures are now all available in their 2017 edition in English and Spanish.
Read Full Story

GI Supply offers the widest variety of GI focused patient education materials on procedural and disease topics. All 40 brochures have been updated to reflect current practice and medications. Written and reviewed by a practicing gastroenterologist, you can be sure your patients will have the information they need after they leave your office.

Learn more about Meducate Patient Education.

GI Supply Opens European Office To Support Global Distributors and Enter New Markets
June 5, 2017 | London, UK

Focusing on global growth, GI Supply hired its first full-time staff in Europe to support its 40+ global distributors.
Read Full Story

Caroline Abrego ( joins GI Supply as European Marketing Manager, and Simon Humphrey-Adam ( joins as Global Growth Leader, entering new markets.

Find more information about becoming a GI Supply distributor.

GI Supply Welcomes Hank Struik To Board of Directors
April 6, 2017 | Camp Hill, PA

GI Supply welcomed Hank Struik to the board of directors at its April 2017 Shareholder Meeting.
Read Full Story

Mr. Struik, who is currently Chairman and CEO of Northfield Medical, brings with him financial, operational, and leadership expertise from past roles at Cardinal Health, Labsco, and as an operating partner at Frazier Healthcare Partners.

Mr. Struik fills Mr. William Alexander’s board seat. GI Supply is tremendously grateful for Mr. Alexander’s leadership and guidance to the company over many years and wish him well as he continues lecturing at The Wharton School of Business at the University of Pennsylvania.

2017 ESGE Guidelines on Colorectal Polypectomy and EMR Call For Tattooing All Lesions
February, 2017 | Lyon, France

European Society of Gastrointestinal Endoscopy released 2017 practice management guidelines for colorectal polypectomy and endoscopic mucosal resection (EMR) which call for tattooing all lesions for future colonoscopy or surgery.
Read Full Story

New guidelines from the European Society of Gastrointestinal Endoscopy (ESGE) detail the latest thinking in colorectal polypectomy and endoscopic mucosal resection (EMR) based on published clinical evidence. Among their recommendations on when and how to prepare and conduct therapeutic colonoscopy procedures includes specific guidance on when and how to tattoo as a standard of care.

“Colonoscopic tattooing is performed to enable future identification, at colonoscopy or surgery, of malignant lesions (proven or suspected), polypectomy, EMR, or ESD sites, difficult-to-detect polyps, or dysplastic areas. All such lesions, other than those definitely located in the cecum, adjacent to the ileocecal valve, or in the low rectum, should be tattooed.”1

Spot® Endoscopic Marker has more than 25 published clinical studies showing the value of post-polypectomy clinical surveillance for future identification of lesions and surgical localization. These guidelines provide a clear summary of these data for Endoscopists and guidance on when to tattoo; All lesions that will need future colonoscopy or surgery should be tattooed.

Read the 2017 ESGE Guidelines Here

Learn more about Spot Endoscopic Marker

1. Ferlitsch M, Moss A, Hassan C, et al. Colorectal polypectomy and endoscopic mucosal resection (EMR): ESGE Clinical Guideline. 2017